Biomarkers and prognostic stratification in psoriatic arthritis
In rheumatic diseases, biomarkers may serve as surrogate endpoints for diagnosis, prognosis, disease activity, therapeutic response and disease outcome. In recent years a great effort has been made to identify useful tools to establish early diagnosis, prognosis and therapeutic response especially i...
Main Authors: | R. Caporali, G. Crepaldi, L. Bogliolo |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2012-06-01
|
Series: | Reumatismo |
Subjects: | |
Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/604 |
Similar Items
-
Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs
by: E. Lubrano, et al.
Published: (2012-06-01) -
Synovial Immunohistological Biomarkers of the Classification of Undifferentiated Arthritis Evolving to Rheumatoid or Psoriatic Arthritis
by: Andrea Cuervo, et al.
Published: (2021-04-01) -
MANUBRIOSTERNAL JOINT INVOLVEMENT IN PSORIATIC ARTHRITIS
by: Hassan Iffat, et al.
Published: (2011-04-01) -
IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01) -
Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis
by: Stephen R. Pennington, et al.
Published: (2021-08-01)